CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed
Drug / intervention
V.A.C. ® Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00224796
NCT00224796Phase 4Completed
CompareCT.gov

A Randomized, Controlled Multicenter Trial of Vacuum Assisted Closure® Therapy in the Treatment and Blinded Evaluation of Amputation Wounds of the Diabetic Foot

KCI USA, Inc·interventional·Posted Sep 23, 2005·Updated Dec 2, 2024

In Brief

A Phase 4 clinical trial evaluating V.A.C. ® System for Diabetic Foot. Completed.

Detailed Summary

The purpose of this study is to compare the effectiveness of Vacuum Assisted Closure® (V.A.C.®) Therapy to moist wound therapy of amputation wounds of the diabetic foot. The primary objective is to determine the effect of V.A.C.® Therapy on the incidence of complete wound closure. Secondary objectives include evaluating the acceleration of wound closure, facilitation of surgical closure, incidence of foot salvage, and incidence of wound complications.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetic Foot
Countries--
Collaborators--

Timeline

Phase 4CompletedFinished
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 23, 2005
Enrollment StartMay 1, 2002
Study CompletionOct 1, 2005
TodayJul 2, 2026
Posted 20.8 years ago

Interventions

V.A.C. ® Systemdevice